FEATURED BLOG

Why Cloudbyz CTMS is the Best Choice for Biotechnology Companies

For biotechnology companies looking to streamline their clinical trial management, reduce time to market, and achieve better outcomes, Cloudbyz CTMS is the solution that delivers. Its specialized features, scalability, and commitment to innovation make it the best choice for managing the complexities of biotechnology clinical trials today and in the future.

View Story

Why Cloudbyz CTMS is the Best Choice for Biotechnology Companies

For biotechnology companies looking to streamline their clinical trial management, reduce time to market, and achieve better outcomes, Cloudbyz CTMS is the solution that delivers. Its specialized features, scalability, and commitment to innovation make it the best choice for managing the complexities of biotechnology clinical trials today and in the future.

View Story

FEATURED BLOG

September 25, 2020 by Ani Mayasandra

We analyzed 164 pharmacovigilance startups impacting the industry. HEPAprint, MEDIKURA, Navro, Embleema & Cloudbyz develop 5 top solutions to watch out for. Learn more in our Global Startup Heat Map!

Categories

All

Blog > Digital Services

A Comprehensive Guide to Setting Up Patient Support and Access Programs for Pharmaceutical Companies

Patient support and access programs are not only a moral imperative but also a strategic decision for pharmaceutical companies. These initiatives contribute to improved patient outcomes, increased brand loyalty, and a positive impact on public health. By understanding patient needs, adhering to regulations, and designing comprehensive, patient-centric programs, pharmaceutical companies can make a meaningful difference in the lives of patients while advancing their own missions of healthcare innovation and accessibility.

Navigating the Path to Clinical Trials: A Guide to Grants Management for Investigators

Grants management is a critical aspect of running successful clinical trials as an investigator. Securing funding, adhering to compliance requirements, and effectively managing resources are key components of this process. By understanding and mastering the art of grants management, investigators can bring their innovative clinical trial ideas to fruition, contributing to advancements in medical science and patient care.

Accelerating Pharmaceutical Drug Market Access: The Role of Investigator-Initiated Trials and Digital Platforms

Investigator-Initiated Trials hold immense potential in advancing pharmaceutical drug development, but they also present significant challenges. Digital platforms and technologies are becoming indispensable tools in overcoming these challenges by streamlining trial management, enhancing collaboration, and accelerating the path to market access for innovative therapies. As the pharmaceutical industry continues to evolve, the integration of digital solutions will play an increasingly critical role in bringing new treatments to patients in need.